Lifeboat Foundation

Diagnosing, Treating, And Preventing Neglected Tropical Diseases — Dr. Maria Elena Bottazzi, BCM National School of Tropical Medicine, Baylor University.

Dr. Maria Elena Bottazzi (https://www.bcm.edu/people-search/maria-bottazzi-18431) is Distinguished Professor of Biology, Associate Dean of the National School of Tropical Medicine, and Professor in the Departments of Pediatrics, Molecular Virology and Microbiology, Integrative Molecular and Biomedical Sciences, and Translational Biology and Molecular Medicine, at Baylor College of Medicine.

Continue reading “Dr. Maria Elena Bottazzi — National School of Tropical Medicine — Baylor College of Medicine” »

Your DNA is in a database.

Your genetic code is probably already in a database, without you ever giving a sample or permission. This video is sponsored by Brilliant. The first 200 people to sign up via https://brilliant.org/veritasium get 20% off a yearly subscription.

Continue reading “Catching Criminals With Their Relative’s DNA” »

Sickle-cell disease is incurable and affects 15,000 people in the UK.

And the National Institute for Health and Care Excellence said the hope of reducing health inequalities for black people, who are predominantly affected and often have poorer health to start with, made the drug worth recommending.

It called it “an innovative treatment”.

Continue reading “First new treatment for sickle cell in 20 years” »

Enterprises of all sizes and across virtually all markets are scrambling to augment their analytics capabilities with artificial intelligence (AI) in the hopes of gaining a competitive advantage in a challenging post-pandemic economy.

Plenty of anecdotal evidence points to AI’s ability to improve analytics, but there seems to be less conversation around how it should be implemented in production environments, let alone how organizations should view it strategically over the long term.

I think so.

A recent study demonstrates that machine learning methods could determine the risk of a viral jump or “spillover” from animals to humans.

Continue reading “Can AI help predict the next pandemic?” »

Gene editing works at low efficiency in dogs.

Circa 2017

‘We have entered the age where the human genome is a real drug target.’

What’s so special about this artificial kidney? The device was engineered to sustainably support a culture of human kidney cells without provoking an immune response.

This means that kidney failure patients can forgo the often painful and uncomfortable dialysis procedures and the lifetime on immunosuppressant drugs that are taken when a kidney transplant is performed and which can have severe side effects. project just earned a $650,000 prize from KidneyX for its first-ever demonstration of a functional prototype.

According to kidney.org, kidney disease causes more deaths than breast cancer or prostate cancer, affecting an estimated 37 million people in the U.S. or 15% of the adult population; more than 1 in 7 adults.

Scientists in Montreal discover a new enzymatic complex that can stop cells from aging, opening the way to possible new cancer therapies.

Researchers at Université de Montréal and McGill University have discovered a new multi-enzyme complex that reprograms metabolism and overcomes “cellular senescence,” when aging cells stop dividing.

In their study published on September 16 2021, in Molecular Cell, the researchers show that an enzyme complex named HTC (hydride transfer complex) can inhibit cells from aging.